Alzheimers Disease Clinical Trials in Dallas, PA

About Alzheimers Disease Clinical Trials in Dallas

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 52 alzheimers disease clinical trials recruiting participants in Dallas, PA. These studies are seeking a combined 21,936 participants. Research is being sponsored by University of Texas Southwestern Medical Center, M.D. Anderson Cancer Center, Pacific Edge Limited and 40 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.